Wellington Management Group LLP reduced its stake in Genpact Limited (NYSE:G - Free Report) by 27.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 284,263 shares of the business services provider's stock after selling 107,726 shares during the period. Wellington Management Group LLP owned approximately 0.16% of Genpact worth $14,321,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. raised its position in shares of Genpact by 59.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock worth $522,000 after buying an additional 3,849 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Genpact by 20.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock worth $486,000 after buying an additional 1,651 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock worth $491,000 after buying an additional 4,561 shares in the last quarter. 111 Capital purchased a new stake in shares of Genpact in the fourth quarter worth $301,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Genpact in the first quarter worth $2,396,000. 96.03% of the stock is owned by institutional investors.
Genpact Trading Up 0.8%
Genpact stock traded up $0.36 during mid-day trading on Friday, reaching $45.33. 1,706,147 shares of the company traded hands, compared to its average volume of 2,081,082. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. The firm's 50 day moving average price is $44.34 and its 200 day moving average price is $46.56. The firm has a market capitalization of $7.90 billion, a price-to-earnings ratio of 15.06, a P/E/G ratio of 1.56 and a beta of 0.92. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.23 billion. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The company's quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's payout ratio is presently 22.59%.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on G. Mizuho increased their price objective on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Wall Street Zen raised Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. JPMorgan Chase & Co. dropped their price target on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Robert W. Baird dropped their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Finally, Needham & Company LLC lifted their price target on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $52.29.
Get Our Latest Stock Analysis on Genpact
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.